Top compounds associated with response to NAT9


Feature Type Standardized
Nominal ANOVA
mRNA pac-1 GDSC1000 pan-cancer AAC 0.066 0.07
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.062 0.07
mRNA BIBR-1532 CTRPv2 pan-cancer AAC 0.066 0.07
mRNA YL54 CTRPv2 pan-cancer AAC 0.071 0.07
mRNA Docetaxel CTRPv2 pan-cancer AAC -0.087 0.07
mRNA XMD14-99 GDSC1000 pan-cancer AAC -0.06 0.07
mRNA Doxorubicin CTRPv2 pan-cancer AAC -0.053 0.07
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.067 0.07
mRNA BRD-K58730230 CTRPv2 pan-cancer AAC 0.13 0.08
mRNA CHIR-99021 CTRPv2 pan-cancer AAC 0.059 0.08
Download CSV